COMPANIES COVERED
Purdue PharmaDownload FREE Report Sample
Download Free sampleOpioid drugs act on the opioid receptors present in the central and peripheral nervous system. The drug class primarily used in relieving pain includes natural, semi-synthetic, and synthetic opioids.Opioids can be administered as oral pills, parenteral, liquids, patches, or lozenges.
Opioids Agonist Drugs Market contains market size and forecasts of Opioids Agonist Drugs in global, including the following market information:
Global Opioids Agonist Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Opioids Agonist Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Opioids Agonist Drugs companies in 2021 (%)
The global Opioids Agonist Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Codeine Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Opioids Agonist Drugs include Purdue Pharma, Titan pharmaceuticals, Boehringer Ingelheim, Janssen Pharmaceuticals, Inc, Sanofi, Sun Pharmaceuticals, Mallinckrodt Pharmaceuticals, Egalet Corporation and Endo Pharmaceuticals Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Opioids Agonist Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Opioids Agonist Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Opioids Agonist Drugs Market Segment Percentages, by Type, 2021 (%)
Codeine
Fentanyl
Meperidine
Methadone
Morphine
Hydrocodone
Global Opioids Agonist Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Opioids Agonist Drugs Market Segment Percentages, by Application, 2021 (%)
Pain Management
Cough Treatment
Diarrhea Treatment
Global Opioids Agonist Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Opioids Agonist Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Opioids Agonist Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Opioids Agonist Drugs revenues share in global market, 2021 (%)
Key companies Opioids Agonist Drugs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Opioids Agonist Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Purdue Pharma
Titan pharmaceuticals
Boehringer Ingelheim
Janssen Pharmaceuticals, Inc
Sanofi
Sun Pharmaceuticals
Mallinckrodt Pharmaceuticals
Egalet Corporation
Endo Pharmaceuticals Inc.
Allergan, Plc
Pfizer Inc
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
